Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dapagliflozin Tablets

Approval Number

国药准字H20233762

Company江苏豪森药业集团有限公司

Registration Date

June 21, 2023

Drug Information

Generic Name

达格列净片

Dosage Form

片剂

Strength

5mg（以C₂₁H₂₅ClO₆计）

Drug Type

化学药品

Registration Date

June 21, 2023

Company Information

Applicant Company

Company Name江苏豪森药业集团有限公司

Company Address

江苏省连云港经济技术开发区

Manufacturing Company

Company Name江苏豪森药业集团有限公司

Company Address

连云港经济技术开发区东晋路5号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy